Roche 454 Life Sciences recently announced that a team of researchers have used the Genome Sequencer FLX system to monitor low-frequency HIV variants from...
GlaxoSmithKline and Idenix Pharmaceuticals, Inc. announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899...
The mobility of gate-keeping molecular flaps could be the key factor to antiviral drug resistance. HIV-1's protease enzyme mutates to elude drugs that block its active...
Global Solutions for Infectious Diseases ("GSID") announced that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective...
NEW DELHI, Sept 9 - India's rejection of patent applications on two life-saving HIV/AIDS drugs last week has been welcomed by health officials, who say it will ensure wider access to the medicines. India has...
* ViiV Healthcare launched, pooling Glaxo and Pfizer drugs * CEO hopes to overtake Gilead, sees Selzentry as key driver LONDON, Nov 3 - GlaxoSmithKline, working alongside Pfizer in an unusual collaboration, aims to regain...
* Net profit 72 cents/share beats 67 cents/share estimate * Revenue increases 31 pct to $1.8 billion * Shares fall 2.3 percent (Recasts, adds company comments, updates stock price) LOS ANGELES, Oct 20 - Gilead...
* Expects late-stage trial result early in Q1 2010 * Research talks progress with Johnson & Johnson's Tibotec * Sees big pharma focusing more on early stage collaborations * Shares fall 2.6 percent after touching...
WASHINGTON, Sept 24 - For the first time ever, an AIDS vaccine protected people from infection with the human immunodeficency virus, lowering the risk of infection by about 30 percent over three years. Here are...
* FDA says promotional DVD contains serious violations * Seeks response with action plan from Abbott by July 28 * Abbott says Magic Johnson DVD no longer in use NEW YORK, July 22 - The...